Member Info for ecovest

Looked ok to me. Not sure what explains slight drop today. Maybe s/p had crept ahead of NAV too far?

Look good - 18% growth. Probably mostly priced in though - it's already risen nicely in anticipation. Not sure I'd be shorting this myself.

Good rise today on the back of this.

So BlueDealer, do you think it's worth taking them up then?

Would have thought this would be up today on the RNS about roads upgrade work, and newspapers also have Osborne's announcements on m-way upgrades.

Market obviously happy. Revenue slightly down, profits up, free cash flow doubled.

Sympathies - Dairy Crest would have been better!

Results look fine to me.Drop is, as you say, down to placing, but this will eventually be good for the s/p as it looks like a decent purchase. While we wait, likely full year dividend of US 4 cents per share (which the placing RNS states will be maintained): "The interim dividend of US1.33 cents per share will be paid on 9 January 2015 to ordinary shareholders on the register at the close of business on 21 November 2014. Subject to financial and trading performance in the second half of 2014/15, we expect to recommend a final dividend of US2.67 cents per share, resulting in a full year dividend of US4 cents per share."

Liberum initiates with a 'Buy' and target of 417p.

This online ad agency/tech firm (main market not Aim) is held by the Slater growth fund and also listed by him as a likely t/o candidate in the Mail. Recent Director sells were to enable one of Europe's largest ad agencies to buy a stake. Big spread though ask price is well within this.

Do you flip all or just some?

Not only Woodford has bought in recently, but also River and Mercantile - they have a great smaller company record.

I know for sure that some of those sells are buys!

The thing is that that relies on companies being proactive, which they often aren't, especially at SME level. UTW dos the proactivity for them.

Looks like I timed my entry right for a change!

Look good - 18% increase in revenues. Two new hospitals added in the summer which should feed though into future results, plus more in the development pipeline.

That's quite a big (200,000 shares - £453,000K) late reported trade from last week.

Greetings Jolly, hope all is well. Managed to buy in this morning at near lowest price (so far!). Looks like a good one and rather oversold.

Decent set of results in September, recent director buy of around £32K. Miton has sold down a bit which maybe explains the s/p has not gone anywhere recently, but they still have around 9%.

Oh and there are still a fair few shrewd institutional investors including Woodford, Slater, Invesco, Norges and others - they're no fools and will I'm sure be keeping management in order. 60% in II hands is a very decent %age. http://markets.ft.com/research/Markets/Tearsheets/Business-profile?s=STOB:LSE